OP0129 A 12-WEEK, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY OF RUZINURAD (SHR4640) IN COMBINATION …
用户aKgJC6g3RnhA
28天前
55
10
已完结
1. 系统已在2025-03-31 11:15:55对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
C Bao, H Ding, Q Dai, J Hu, L Yang, Z Jiang…
Annals of the Rheumatic …, 2024
Elsevier
… generally balanced among ruzinurad 10 mg, ruzinurad 5 mg, … of patients in the ruzinurad groups achieved the target sUA level … demonstrated superior effects of ruzinurad over placebo. …
